LumiThera has purchased the assets of MacuLogix through its wholly owned subsidiary, according to a press release.
MacuLogix developed the AdaptDx Pro dark adaptometer, a wearable device used to diagnose dry age-related macular degeneration. It launched in 2020.
“AdaptDx Pro can identify dry AMD patients at the earliest timepoint, in advance of pathology and before vision loss,” Clark E. Tedford, PhD, president and CEO of LumiThera, said in the release. “The AdaptDx wearable, light-based early diagnostic for dry AMD adds a complementary assessment of retinal health to the